Mayo Clinic Cancer Researcher Keith Knutson joined 'Fox News Sunday' to discuss the progress on the vaccine and the significance of the breakthrough in fighting the disease. A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. At the Society for Immunotherapy of Cancer earlier this month in Texas, researchers shared updated findings from a study of a new vaccine designed to target triple-negative breast cancer, a press release stated.
Triple-negative breast cancer (TNBC) is a highly aggressive type of breast cancer , according to the American Cancer Society (ACS). 4 HIDDEN SIGNS OF BREAST CANCER TO WATCH FOR: ‘YOU KNOW YOUR BODY’ TNBC grows and spreads faster than less aggressive types and is more difficult to treat. G.
Thomas Budd, M.D., lead study researcher, is pictured in the Cleveland Clinic lab.
"The investigational vaccine represents a potential new way to combat breast cancer," he said. (Courtesy of Cleveland Clinic) The breast cancer vaccine that Cleveland Clinic is studying is the first that aims to prevent triple-negative breast cancer from developing, according to G. Thomas Budd, M.
D., principal investigator of the phase 1 study at Cleveland Clinic’s Cancer Institute. AFTER A BREAST CANCER DIAGNOSIS, HERE ARE 10 IMPORTANT THINGS YOU SHOULD DO, EXPERTS SAY The vaccine uses a protein found in breast tissue that is dedicated to lactation — called α-lactalbumin — which.
